Details for Patent: 10,398,785
✉ Email this page to a colleague
Which drugs does patent 10,398,785 protect, and when does it expire?
Patent 10,398,785 protects DOCIVYX and is included in one NDA.
This patent has eight patent family members in five countries.
Drugs Protected by US Patent 10,398,785
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Avyxa Holdings | DOCIVYX | docetaxel | SOLUTION;INTRAVENOUS | 215813-001 | Nov 22, 2022 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | Y | ⤷ Sign Up | ||||
| Avyxa Holdings | DOCIVYX | docetaxel | SOLUTION;INTRAVENOUS | 215813-002 | Nov 22, 2022 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | Y | ⤷ Sign Up | ||||
| Avyxa Holdings | DOCIVYX | docetaxel | SOLUTION;INTRAVENOUS | 215813-003 | Nov 22, 2022 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | Y | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
